cervic
cancer
second
lead
caus
cancer
death
among
women
worldwid
human
papillomaviru
hpv
infect
close
associ
cervic
cancer
hpv
genotyp
identifi
hpv
type
associ
hpvrelat
cervic
cancer
case
studi
protein
physic
interact
lead
dysfunct
protein
bind
retinoblastoma
protein
prb
activ
cell
cycleassoci
gene
protein
consist
express
cervic
cancer
cell
two
oncoprotein
repres
attract
target
develop
vaccin
immunotherapeut
strategi
hpvassoci
diseas
recent
nakagawa
et
al
demonstr
presenc
memori
cell
women
whose
hpv
infect
clear
conclud
cytotox
lymphocyt
ctl
respons
antigen
import
antigen
control
infect
thu
ctl
activ
may
major
immun
respons
control
persist
infect
hpv
infect
epithelium
lower
femal
genit
tract
lead
cervic
carcinoma
one
strategi
cervic
cancer
might
induc
effect
mucos
immun
aim
toward
inhibit
genit
hpv
transmissioninfect
erad
hpvinfect
cell
sever
studi
demonstr
oral
immun
viral
antigen
induc
antigenspecif
humor
cellular
immun
oral
administr
way
increas
mucos
immun
gener
conveni
parenter
administr
lactic
acid
bacteria
lab
rel
safe
exhibit
adjuv
effect
modul
immun
respons
may
good
deliveri
vehicl
mucos
immun
addit
surfacedisplay
antigen
lactobacilli
reportedli
effici
induc
antigen
present
dendrit
cell
surfac
local
antigen
lactococci
report
induc
greater
cellular
immun
compar
intracellular
secret
form
furthermor
previous
demonstr
oral
administr
viral
antigen
display
lactobacillu
casei
l
casei
sever
acut
respiratori
syndromeassoci
coronaviru
protein
protein
effect
induc
antigenspecif
neutral
antibodi
antitumor
respons
mice
studi
use
pgsa
gene
product
transmembran
protein
deriv
acid
synthetas
complex
pgsbca
system
bacillu
subtili
surfac
anchor
motif
surfac
display
antigen
l
casei
examin
whether
oral
administr
antigen
express
l
casei
could
elicit
cellular
immun
induct
effect
immun
assess
product
antigenspecif
serum
igg
mucos
iga
quantif
antigenspecif
cell
splenocyt
local
lymphocyt
enzymelink
immunospot
elispot
assay
final
test
vivo
tumor
regress
effect
l
casei
mous
tumor
model
seed
tumor
cell
line
gener
express
vector
pkv
fig
encod
pgsa
fuse
protein
hpv
type
hce
promot
phat
replac
promot
fructosebisphosph
aldolas
pald
gene
origin
l
casei
proteinencod
gene
downstream
acid
synthetas
pgsa
gene
replac
encod
protein
briefli
gene
encod
protein
amplifi
revers
transcriptionpcr
caski
cell
line
use
forward
gga
tcc
atg
cac
caa
aag
aga
act
revers
tct
aga
tca
tta
cag
ctg
ggt
ttc
tct
acg
tg
primer
contain
bamhi
xbai
site
respect
gene
phat
replac
fragment
use
restrict
enzym
site
plasmid
first
establish
e
coli
transform
l
casei
bl
electropor
e
coli
cell
grown
medium
erythromycin
recombin
express
host
l
casei
bl
cell
grown
mr
medium
erythromycin
collect
cell
wash
pb
kill
boil
min
follow
lyophil
lactobacillu
casei
cell
cell
wash
thrice
pb
resuspend
sonic
pb
contain
mm
phenylmethylsulfonyl
fluorid
pmsf
sampl
place
ice
subsequ
step
perform
ice
cell
lysat
mix
sampl
buffer
boil
min
sampl
centrifug
rpm
min
supernat
resolv
sdspage
transfer
onto
polyvinyliden
fluorid
pvdf
membran
millipor
usa
protein
band
detect
label
polyclon
antipgsa
antibodi
polyclon
goat
antibodi
santa
cruz
biotechnolog
ca
usa
follow
addit
horseradish
peroxidas
hrp
conjug
antigoat
igg
antibodi
cell
signal
technolog
usa
dilut
skim
milk
pb
blot
visual
chemiluminesc
use
ecl
detect
kit
ge
healthcar
uppsala
sweden
lactobacillu
casei
cell
cell
harvest
wash
twice
pb
resuspend
te
buffer
contain
polyclon
antibodi
cell
suspens
incub
h
wash
twice
pb
incub
ice
h
alexa
fluor
antigoat
igg
antibodi
molecular
probe
usa
te
buffer
cell
wash
twice
pb
centrifug
cell
pellet
resuspend
pb
examin
either
bd
facscalibur
flow
cytomet
analyz
cellquest
softwar
ca
usa
fluoresc
microscop
carl
zeiss
microimag
inc
ny
usa
photograph
axiocam
hrc
carl
zeiss
microimag
inc
femal
mice
purchas
dae
han
biolink
chungju
korea
hous
specif
pathogenfre
anim
facil
korea
research
institut
bioscienc
biotechnolog
daejeon
korea
recombin
l
casei
cell
constitut
express
fusion
protein
pgsa
harvest
wash
thrice
pb
resuspend
pb
cellsml
oral
dose
recombin
lactobacilli
dilut
pb
cell
suspens
administ
daili
via
intragastr
rout
day
immun
sera
taken
day
store
use
intestin
lavag
obtain
wash
intestin
ml
icecold
salin
contain
proteas
inhibitor
sampl
centrifug
rpm
min
supernat
store
analysi
blood
collect
eye
bleed
spleen
mesenter
lymph
node
mln
harvest
asept
vagin
secret
collect
wash
vagin
tract
steril
pb
contain
mm
pmsf
sampl
clear
centrifug
rpm
remov
tissu
cellular
debri
store
use
vagin
lymphocyt
isol
describ
dupuy
et
al
briefli
mous
vagina
excis
cervix
remov
vagin
tissu
minc
hank
buffer
salt
solut
hbss
wash
time
mm
edta
hbss
digest
h
rpmi
invitrogengibco
ca
usa
supplement
volvol
fb
mgml
collagenas
type
mgml
dispas
remain
cell
filter
steril
gauz
mesh
wash
rpmi
contain
fb
lymphocyt
purifi
use
ficollhistopaqu
mo
usa
purifi
vagin
lymphocyt
five
mice
pool
elispot
analysi
quantif
antigenspecif
igg
iga
antibodi
level
maxisorp
plate
nunc
denmark
incub
overnight
purifi
ngwell
coat
buffer
sodium
carbon
sodium
azid
ph
use
elisa
coat
antigen
recombin
protein
produc
e
coli
briefli
gene
insert
vector
novagen
darmstadt
germani
transform
e
coli
induc
protein
isol
cell
lysat
purifi
use
ninta
affin
column
qiagen
ca
usa
use
coat
plate
coat
plate
block
skim
milk
pb
h
wash
twice
pb
contain
load
serial
dilut
serum
sampl
detect
igg
tissu
wash
sampl
detect
local
iga
incub
h
hrpconjug
goat
antimous
igg
iga
skim
milk
pb
ad
detect
antigenspecif
antibodi
follow
incub
plate
wash
tmb
substrat
reagent
ad
well
incub
min
room
temperatur
dark
reaction
stop
sulfur
acid
final
measur
use
elisa
reader
perkin
elmer
usa
elispot
assay
perform
use
mous
elispot
kit
bd
bioscienc
ca
usa
accord
manufactur
instruct
briefli
day
singl
cell
prepar
antimous
captur
antibodi
pb
distribut
bdtm
elispot
plate
plate
incub
overnight
wash
block
solut
contain
complet
rpmi
media
ad
plate
incub
h
freshli
isol
lymphocyt
ad
cell
per
well
medium
contain
peptid
amino
acid
contain
mhc
class
epitop
plate
incub
day
cell
discard
plate
sequenti
treat
biotinyl
antimous
antibodi
streptavidinhrp
substrat
solut
plate
wash
deioniz
water
dri
least
h
dark
spot
automat
count
use
imunoscan
entri
analyz
cellular
technolog
ltd
oh
usa
neg
control
number
spotform
cell
sfc
per
cell
count
absenc
peptid
less
cell
singl
cell
suspens
prepar
spleen
mln
experi
cell
incub
media
contain
peptid
evydfafrdl
golgiplug
bd
bioscienc
overnight
cell
wash
stain
phycoerythrin
pe
conjug
monoclon
rat
antimous
antibodi
bd
bioscienc
follow
intracellular
cytokin
stain
fitcconjug
antibodi
bd
bioscienc
use
cytofixcytoperm
kit
bd
bioscienc
accord
manufactur
instruct
fluoresc
intens
measur
facscalibur
flow
cytometri
analyz
use
cellquest
softwar
prevent
experi
mice
eight
per
group
oral
administ
lactobacillu
express
antigen
describ
one
week
first
administr
mice
challeng
tumor
cell
cell
per
mous
cotransform
activ
ra
oncogen
tumor
challeng
perform
subcutan
inject
left
inguin
region
measur
therapeut
efficaci
oral
administr
recombin
l
l
caseipgsa
initi
day
challeng
day
boost
perform
day
cell
kindli
provid
tc
wu
john
hopkin
univers
baltimor
md
cultur
supplement
volvol
fb
hyclon
logan
ut
usa
mm
nonessenti
amino
acid
tumor
size
express
tumor
area
determin
monitor
perpendicular
diamet
tumor
time
week
use
calip
examin
role
cell
antitumor
effect
l
perform
vivo
antibodi
deplet
previous
describ
follow
tumor
challeng
monoclon
antibodi
mab
mab
use
cell
deplet
respect
initi
deplet
perform
intraperiton
inject
mab
per
day
day
check
role
cell
prevent
antitumor
model
deplet
initi
simultan
first
oral
administr
recombin
l
casei
week
tumor
challeng
deplet
continu
done
week
week
therapeut
antitumor
model
initi
deplet
start
day
tumor
challeng
deplet
continu
done
week
week
statist
analys
perform
use
student
test
data
p
valu
taken
indic
statist
signific
differ
first
construct
lactobacillu
express
vector
pkv
pgsa
use
anchor
protein
direct
surfac
express
protein
l
casei
fig
transform
l
casei
cell
harbor
pkv
pgsa
pkv
grown
overnight
induct
recombin
protein
express
confirm
proper
express
protein
equal
amount
whole
cell
lysat
recombin
l
casei
harbor
pkvpgsa
resolv
sdspage
subject
western
blot
analysi
use
antipgsa
antibodi
fig
lane
contain
l
fig
lane
contain
kda
immunoreact
band
like
repres
fusion
protein
compris
protein
pgsa
surfac
display
motif
smaller
band
repres
express
pgsa
anchor
protein
detect
l
caseipgsa
lysat
fig
lane
surfac
local
protein
l
casei
confirm
flow
cytometri
immunofluoresc
microscopi
use
polyclon
antibodi
alexa
fluor
antigoat
igg
antibodi
fac
analysi
reveal
signific
increas
fluoresc
intens
l
mean
fluoresc
intens
mfi
compar
l
caseipgsa
mfi
fig
immunofluoresc
microscopi
analysi
show
l
immunostain
posit
control
l
caseipgsa
fig
data
demonstr
recombin
protein
effici
express
surfac
l
determin
whether
recombin
lactobacilli
possess
abil
induc
antibodi
product
surfacedisplay
antigen
femal
mice
oral
immun
l
l
caseipgsa
cfu
day
boost
day
serum
igg
mucos
iga
level
determin
day
elisa
use
purifi
protein
coat
antigen
fig
mean
igg
titer
sera
mice
immun
l
compar
serum
sampl
l
caseipgsaimmun
control
group
day
mean
titer
serum
igg
mice
immun
oral
l
respect
indic
mean
titer
serum
igg
l
mice
increas
first
second
boost
respect
contrast
igg
titer
l
caseipgsaimmun
mice
significantli
increas
day
fig
result
suggest
signific
humor
respons
induc
oral
immun
l
examin
mucos
immun
respons
detect
product
mucos
iga
antibodi
intestin
vagin
lavag
fluid
collect
oral
immun
mice
day
postimmun
pi
result
reveal
mice
immun
l
develop
signific
iga
antibodi
level
intestin
vagin
mucosa
fig
c
compar
mean
optic
densiti
od
intestin
iga
l
caseipgsaimmun
mice
l
mice
significantli
higher
p
mean
od
valu
intestin
fluid
immun
l
significantli
enhanc
first
second
boost
respect
contrast
level
intestin
iga
l
caseipgsaimmun
mice
significantli
differ
follow
initi
immun
first
second
boost
fig
day
pi
mean
od
vagin
wash
l
caseipgsa
l
mice
similar
vs
respect
contrast
compar
l
caseipgsaimmun
mice
immun
l
demonstr
higher
vagin
iga
respons
follow
first
vs
second
vs
boost
fig
vagin
iga
level
l
mice
significantli
increas
boost
p
respons
observ
l
caseipgsatr
mice
data
indic
system
serum
igg
mucos
intestinalvagin
iga
humor
immun
respons
induc
oral
administr
l
investig
cmi
respons
gener
oral
administr
l
mice
perform
flow
cytometr
analysi
elispot
assay
vaccin
l
caseipgsa
l
murin
splenocyt
prepar
day
pi
cell
respons
observ
stimul
class
irestrict
peptid
evydfafrdl
shown
fig
observ
significantli
higher
number
cell
mice
immun
l
compar
mice
vaccin
dose
l
caseipgsa
l
vaccin
mice
cell
respons
increas
approxim
threefold
first
boost
fivefold
second
boost
p
effect
seen
l
caseipgsaimmun
mice
previous
report
popul
neg
cell
observ
respons
ctl
peptid
fig
next
cell
evalu
splenocyt
l
caseipgsa
l
mice
use
elspot
assay
consist
find
l
mice
show
signific
cmi
respons
spotform
cell
sfc
cell
second
boost
p
contrast
mice
oral
dose
l
caseipgsa
show
moder
respons
cell
fig
similar
seen
preimmun
mice
data
shown
taken
togeth
result
indic
cmi
respons
induc
splenocyt
mice
oral
immun
l
local
cellular
respons
import
elimin
cell
locat
mucosa
investig
local
cmi
respons
mesenter
lymph
node
mln
vagin
lymphocyt
mice
oral
treat
l
caseipgsa
l
fig
elispot
assay
number
cell
mln
cell
increas
approxim
second
boost
l
mice
compar
control
mice
p
fig
contrast
effect
seen
l
caseipgsaimmun
mice
vagin
lymphocyt
number
cell
increas
approxim
sevenfold
second
boost
l
mice
p
fig
result
indic
oral
immun
l
appear
effect
method
induc
local
cmi
respons
mln
vagina
mice
determin
whether
oral
administ
l
elicit
effect
protect
immun
progress
tumor
cell
mice
oral
treat
l
caseipgsa
l
day
boost
day
day
mice
challeng
tumor
cell
cell
per
mous
subcutan
inject
left
inguin
region
fig
mice
oral
dose
l
caseipgsa
develop
tumor
within
week
tumor
inject
contrast
mice
immun
l
remain
tumor
free
week
postchalleng
group
remain
tumor
free
day
postchalleng
fig
thirtyseven
day
tumor
cell
inject
averag
tumor
size
l
mice
significantli
p
smaller
l
caseipgsaimmun
mice
fig
consist
find
mice
immun
l
caseipgsa
succumb
tumor
within
day
tumor
inocul
wherea
mice
immun
l
exhibit
surviv
time
period
surviv
day
tumor
inocul
fig
result
indic
oral
administr
l
elicit
antitumor
effect
tumor
cell
mice
analyz
therapeut
potenti
oral
administ
l
mice
establish
tumor
mice
oral
treat
l
caseipgsa
l
day
subcutan
inocul
tumor
cell
mice
oral
dose
l
caseipgsa
develop
tumor
within
week
tumor
inject
contrast
mice
immun
l
remain
tumor
free
week
tumor
inject
group
still
tumor
free
day
tumor
challeng
fig
thirtyfour
day
tumor
cell
inject
averag
tumor
size
l
mice
significantli
p
smaller
l
caseipgsaimmun
mice
fig
final
none
mice
immun
l
caseipgsa
surviv
day
tumor
inject
wherea
half
mice
immun
l
surviv
remain
mice
surviv
day
inocul
tumor
fig
thu
therapi
experi
observ
oral
administr
l
elicit
antitumor
effect
tumor
cell
mice
cellular
immun
mediat
cell
often
action
secret
cytokin
cytolyt
activ
respect
determin
subset
lymphocyt
import
antitumor
effect
tumor
cell
perform
vivo
antibodi
deplet
experi
deplet
cell
accomplish
intraperiton
inject
antibodi
respect
shown
fig
prevent
antitumor
effect
abrog
either
cell
deplet
l
mice
addit
therapeut
model
l
mice
deplet
cell
prior
tumor
challeng
consist
develop
tumor
regardless
l
treatment
fig
taken
togeth
result
indic
cell
essenti
antitumor
effect
gener
oral
administr
recombin
l
consid
cervic
cancer
occur
vagin
mucosa
highli
associ
vaccin
capabl
induc
cmi
antigen
might
prove
effect
erad
cervic
tumor
cell
develop
effect
recombin
lactobacillusbas
oral
vaccin
test
abil
induc
system
local
immun
respons
therapeut
effect
tumor
mucos
case
oral
immun
sever
advantag
rout
antigen
deliveri
includ
conveni
costeffect
importantli
induct
local
system
immun
respons
oppos
parenter
vaccin
elicit
system
immun
respons
mucos
vaccin
purpos
lactic
acid
bacteria
attract
deliveri
vehicl
consid
safer
mani
live
vaccin
carrier
eg
salmonella
e
coli
vaccinia
chose
l
casei
good
agent
oral
vaccin
due
high
intrins
adjuv
effect
abil
increas
innat
immun
l
casei
strain
use
vaccin
vehicl
studi
activ
immatur
human
bone
marrow
dendrit
cell
upregul
secret
surfac
express
costimulatori
molecul
unpublish
data
cellmedi
immun
respons
play
crucial
role
protect
host
invad
pathogen
studi
investig
feasibl
target
oncoprotein
vaccin
develop
control
hpvassoci
lesion
show
oral
treatment
mice
protein
display
l
casei
could
induc
serum
igg
mucos
iga
product
cell
respons
system
mucos
immun
system
signific
increas
cell
vagin
lymphocyt
l
mice
second
boost
mucos
immun
system
induct
effector
site
vaccin
oral
administ
mean
induct
site
mainli
intestin
region
somewhat
distant
effector
site
vagin
region
therefor
possibl
cmi
respons
distant
effector
site
could
delay
howev
found
number
cell
l
mice
significantli
higher
l
caseipgsaimmun
mice
importantli
vivo
mous
tumor
model
oral
administ
l
show
antitumor
effect
murin
tumor
evidenc
reduc
tumor
size
increas
surviv
rate
versu
mice
receiv
control
l
caseipgsa
immun
accord
observ
vivo
deplet
cell
mab
mab
complet
abrog
tumor
activ
mice
oral
administr
l
result
show
cell
essenti
antitumor
immun
tumor
human
clinic
studi
use
l
casei
express
patient
cervic
intraepitheli
neoplasia
check
safeti
efficaci
current
progress
addit
administr
recombin
l
casei
express
may
enhanc
therapeut
efficaci
collect
find
suggest
recombin
l
casei
express
antigen
may
promis
therapeut
vaccin
candid
cervic
cancer
addit
surfac
display
system
could
use
design
vaccin
mucos
transmit
pathogen
